Has Kari Uusinarkaus, MD received payments from drug or device companies?

Yes. Drug and device makers reported $519,603 in general payments to Kari Uusinarkaus, MD across 600 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kari Uusinarkaus, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kari Uusinarkaus, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kari Uusinarkaus, MD

Family Medicine · Woodland Park, CONPI 1780653444

Payments from drug & device makers

$519,603in general payments, 2019–2025

Across 600 payments — averaging $866.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$138K
Novo Nordisk$116K
Novo Nordisk AS$84K
Regeneron$63K
Esperion Therapeutics, Inc.$35K
Amarin Pharma, Inc.$22K
plus $61K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	81	$138,407
Novo Nordisk	94	$116,256
Novo Nordisk AS	113	$83,588
Regeneron	37	$63,111
Esperion Therapeutics, Inc.	67	$34,731
Amarin Pharma, Inc.	55	$22,092
GSK	4	$13,618
Sanofi-aventis U.S. LLC	16	$11,848
Astellas Pharma US Inc	8	$7,458
AstraZeneca	17	$5,843
Kowa Pharmaceuticals America, Inc.	7	$3,795
Johnson & Johnson	9	$3,625
Janssen Global Services, LLC	4	$3,536
Medicure Pharma Inc.	5	$2,672
Novartis	11	$2,629
Idorsia Pharmaceuticals US Inc	3	$1,324
Mylan Specialty L.p.	1	$891
Regeneron Healthcare Solutions, Inc.	8	$599
Heartflow, Inc.	5	$380
Lilly USA, LLC	12	$378
W. L. Gore & Associates, Inc.	2	$340
Medtronic	3	$298
Pfizer	4	$283
Boehringer Ingelheim	2	$233
Amryt Pharma Holdings Ltd	3	$206
Therapeuticsmd, Inc.	2	$161
Bayer	2	$138
Daiichi Sankyo Inc.	1	$125
Eisai Inc.	1	$125
Janssen Scientific Affairs, LLC	1	$111
Avadel CNS Pharmaceuticals, LLC	1	$109
Kaneka Medical America LLC	1	$104
Biohaven Pharmaceutical Holding Company Ltd.	2	$102
Ionis Pharmaceuticals, Inc.	1	$92
Mannkind Corporation	2	$84
Edwards Lifesciences	3	$53
Boston Scientific	2	$51
Biohaven Pharmaceuticals, Inc.	2	$51
Corcept Therapeutics	1	$50
Sunovion Pharmaceuticals Inc.	1	$43
Hologic Sales And Service, LLC	1	$22
E.r. Squibb & Sons, L.L.C.	1	$15
Merck	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$12
Travere Therapeutics, Inc.	2	$2

How this compares

$519,603 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024

$44,890

Medicare patients

144

Services billed

603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Woodland Park

Clint FlanaganDacono$7.6M
Larry OdekirkCastle Rock$6.3M
Ripley HollisterColorado Springs$5.5M
Timothy ColanderAurora$3.1M
Mia ScottDenver$993K
Matthew LewisAurora$960K
Ethan LazarusDenver$688K
Patrick BarryFraser$568K
Astrid LampeyFraser$568K
Robert WilliamsGolden$480K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →